(DCNF)—President Joe Biden’s administration has refrained from pressing the European Union (EU) about its new law weighing heavily and disproportionately on American tech companies, The Washington Post reported on Thursday.
The EU’s Digital Markets Act (DMA) officially came into effect Thursday and imposes penalties of up to 20% of a company’s yearly revenue for repeated violations. The DMA is antitrust regulation primarily targeting dominant platforms in the EU, mostly American companies like Alphabet, Apple, Amazon, Meta and Microsoft; but the Biden administration did not firmly challenge the EU to mitigate potential detrimental impacts of the legislation on U.S. firms, according to the Post.
Industry groups sent a letter to the White House warning about the law, asserting “the DMA’s regulatory cudgel is pointed squarely at five leading American companies.” The Biden administration reportedly sent two letters to the EU expressing worries but it did not take a tough stance against it, individuals familiar with the situation told the Post.
The DMA targets “gatekeepers,” which are platforms that “provide an important gateway between businesses and consumers in relation to core platform services,” according to the European Commission. The DMA prohibits companies from operating in the EU in a way that gives their products and services special advantages, such as in app stores, search engines and web browsers. For instance, the DMA makes it illegal to compel companies to use a platform’s payment system to be on its app store, according to the EC.
“The Biden administration has made an intentional decision, and concerted effort, to work with the European Union,” Jorn Fleck, Europe Center senior director at the Atlantic Council, told the Post. “Not just ‘Europe’ writ large, not just through NATO which is the traditional go-to, not just through the bilateral relationships with key countries in Europe, but specifically also with the E.U.”
One letter notes the Biden administration’s opposition to the law targeting American companies, but does not contain warnings about it, based on the contents reported by Politico.
“We oppose efforts specifically designed to target only U.S. companies,” it states.
The Biden administration prioritized collaborating with the EU on the war in Ukraine over safeguarding American tech companies, according to the Post.
“The Ukraine situation has sucked the oxygen out of the room,” a U.S. industry executive told the Post. “The Biden administration has worked very hard to get the Europeans and the U.S. on the same page when it comes to national security type issues.”
Democratic lawmakers advocated for the president to enable the EU to enforce the DMA on American companies because it aligns with the Biden administration’s antitrust agenda, according to a December letter.
The White House and EU did not immediately respond to the Daily Caller News Foundation’s request for comment.
All content created by the Daily Caller News Foundation, an independent and nonpartisan newswire service, is available without charge to any legitimate news publisher that can provide a large audience. All republished articles must include our logo, our reporter’s byline and their DCNF affiliation. For any questions about our guidelines or partnering with us, please contact [email protected].
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.
